GSK Seeks Ax Of Zofran Birth Defect Claims
GlaxoSmithKline on Tuesday asked a Massachusetts federal judge to toss certain claims in multidistrict litigation alleging that its anti-nausea drug Zofran caused birth defects, saying that the patients hadn't shown the...To view the full article, register now.
Already a subscriber? Click here to view full article